drug · small molecule
LB-100
Phase 2updated 3mo agoby $LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 6 investigational indications.
targets
Serine/threonine-protein phosphatase 5Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoformSerine/threonine-protein phosphatase 2A catalytic subunit beta isoform
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that